日本語 
Biotech
Kaigene has signed this exclusive licensing arrangement with Taisho Pharmaceutical, kind of to help build and then commercialize its next-generation autoimmune treatment KG006, specifically in Japan. So basically under the…
FUJIFILM Biotechnologies Targets Bottleneck in Biologics Production
FUJIFILM Biotechnologies has introduced ShunzymeX which functions as a precision purification technology…
ISCT and JSRM Commit to 5-Year iPSC Therapy Expansion
The International Society for Cell and Gene Therapy together with the Japanese…
PHCbi Leverages Real-Time Monitoring for Cell Therapy
PHC Corporation’s Biomedical Division has launched LiCellGrow, a new cell expansion system…
Total Brain Care Partners with Jonan Shingaku Kenkyusha
Total Brain Care has started a content partnership with Jonan Shingaku Kenkyusha,…
Syd Life AI boosts Japan market expansion
iamYiam, a global AI health tech company specializing in improving well-being and…
Takeda Commits Over $1.7 Billion to AI-Driven Drug Discovery in Major Partnership with Iambic
One of Japan's largest pharmaceutical companies, Takeda Pharmaceutical Company, has ramped up…
Quali Inc. Raises ¥1.8B in Series A, Begins Operations
Quali Corporation (hereinafter, Quali) has raised 1.8 billion yen in its Series…
Fujitsu Japan and JMDC Team Up on Healthcare Data
Fujitsu Japan and JMDC announced that they officially began a collaboration on…
FUJIFILM Biotechnologies Targets Bottleneck in Biologics Production
FUJIFILM Biotechnologies has introduced ShunzymeX which functions as a precision purification technology…
ISCT and JSRM Commit to 5-Year iPSC Therapy Expansion
The International Society for Cell and Gene Therapy together with the Japanese…
PHCbi Leverages Real-Time Monitoring for Cell Therapy
PHC Corporation’s Biomedical Division has launched LiCellGrow, a new cell expansion system…
Total Brain Care Partners with Jonan Shingaku Kenkyusha
Total Brain Care has started a content partnership with Jonan Shingaku Kenkyusha,…
Syd Life AI boosts Japan market expansion
iamYiam, a global AI health tech company specializing in improving well-being and…
Takeda Commits Over $1.7 Billion to AI-Driven Drug Discovery in Major Partnership with Iambic
One of Japan's largest pharmaceutical companies, Takeda Pharmaceutical Company, has ramped up…
Quali Inc. Raises ¥1.8B in Series A, Begins Operations
Quali Corporation (hereinafter, Quali) has raised 1.8 billion yen in its Series…
Fujitsu Japan and JMDC Team Up on Healthcare Data
Fujitsu Japan and JMDC announced that they officially began a collaboration on…
English